Abstract
Microparticles (MPs) are cellular vesicles produced by all cells in response to apoptosis or cellular activation. In this brief review, the evidence that MPs mediate the thrombotic propensity that characterizes patients with cancer is evaluated. It is concluded that while considerable data exist to support a critical pathophysiologic role of host or tumor cell-derived MPs in cancer-associated thrombosis, causality is not yet firmly established. The results of prospective clinical studies that are currently underway should clarify any causative relationship.
| Original language | English |
|---|---|
| Pages (from-to) | S80-S83 |
| Journal | Thrombosis Research |
| Volume | 125 |
| DOIs | |
| Publication status | Published - Apr 2010 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Cancer
- Microparticle
- Thrombosis
- Tissue factor
Fingerprint
Dive into the research topics of 'Membrane microparticles in VTE and cancer'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver